Entasis Therapeutics up 181% amid Covid-19 frenzy

This post was originally published on this site

Ultra-thinly traded nano cap Entasis Therapeutics Holdings (ETTX +180.6%) rockets north on a 6x surge in volume, albeit on modest turnover of 72K shares, apparently being swept up in the market’s frenzied buying of anything related to COVID-19 treatments or vaccines.

The company has not announced any specific coronavirus programs. It has four candidates in its pipeline, all antibacterials.

Source: dailystockbuzz

Leave a comment

Your email address will not be published. Required fields are marked *